Logo (Actavis) 435 (Lamotrigine Extended-Release 50 mg)

Pill with imprint Logo (Actavis) 435 is Gray, Round and has been identified as Lamotrigine Extended-Release 50 mg. It is supplied by Actavis Pharma, Inc..

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo (Actavis) 435

Save up to 80% off prescription medications

Click here for your free Discount Card

Lamotrigine Extended-Release

Imprint

Logo (Actavis) 435

Strength

50 mg

Color

Gray

Size

9.00 mm

Shape

Round

Availability

Prescription only

Drug Class

Triazine anticonvulsants

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Actavis Pharma, Inc.

National Drug Code (NDC)

00228-1435

Inactive Ingredients

hypromelloses, lactose monohydrate, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:2), silicon dioxide, magnesium silicate, titanium dioxide, triethyl citrate, FD&C Blue No. 2, FD&C Red No. 40, FD&C Yellow No. 6, triacetin

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer